Immune determinants of COVID-19 disease presentation and severity

被引:0
|
作者
Petter Brodin
机构
[1] Karolinska Institutet,Science for Life Laboratory, Department. of Women’s and Children’s Health
[2] Karolinska University Hospital,Pediatric Rheumatology
来源
Nature Medicine | 2021年 / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
COVID-19, caused by SARS-CoV-2 infection, is mild to moderate in the majority of previously healthy individuals, but can cause life-threatening disease or persistent debilitating symptoms in some cases. The most important determinant of disease severity is age, with individuals over 65 years having the greatest risk of requiring intensive care, and men are more susceptible than women. In contrast to other respiratory viral infections, young children seem to be less severely affected. It is now clear that mild to severe acute infection is not the only outcome of COVID-19, and long-lasting symptoms are also possible. In contrast to severe acute COVID-19, such ‘long COVID’ is seemingly more likely in women than in men. Also, postinfectious hyperinflammatory disease has been described as an additional outcome after SARS-CoV-2 infection. Here I discuss our current understanding of the immunological determinants of COVID-19 disease presentation and severity and relate this to known immune-system differences between young and old people and between men and women, and other factors associated with different disease presentations and severity.
引用
收藏
页码:28 / 33
页数:5
相关论文
共 50 条
  • [21] Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis
    Jesenak, Milos
    Brndiarova, Miroslava
    Urbancikova, Ingrid
    Rennerova, Zuzana
    Vojtkova, Jarmila
    Bobcakova, Anna
    Ostro, Robert
    Banovcin, Peter
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [22] Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity
    Young, Barnaby E.
    Ong, Sean W. X.
    Ng, Lisa F. P.
    Anderson, Danielle E.
    Chia, Wan Ni
    Chia, Po Ying
    Ang, Li Wei
    Mak, Tze-Minn
    Kalimuddin, Shirin
    Chai, Louis Yi Ann
    Pada, Surinder
    Tan, Seow Yen
    Sun, Louisa
    Parthasarathy, Purnima
    Fong, Siew-Wai
    Chan, Yi-Hao
    Tan, Chee Wah
    Lee, Bernett
    Rotzschke, Olaf
    Ding, Ying
    Tambyah, Paul
    Low, Jenny G. H.
    Cui, Lin
    Barkham, Timothy
    Lin, Raymond Tzer Pin
    Leo, Yee-Sin
    Renia, Laurent
    Wang, Lin-Fa
    Lye, David Chien
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2932 - E2942
  • [23] Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19
    Janssen, Nico A. F.
    Grondman, Inge
    de Nooijer, Aline H.
    Boahen, Collins K.
    Koeken, Valerie A. C. M.
    Matzaraki, Vasiliki
    Kumar, Vinod
    He, Xuehui
    Kox, Matthijs
    Koenen, Hans J. P. M.
    Smeets, Ruben L.
    Joosten, Irma
    Brueggemann, Roger J. M.
    Kouijzer, Ilse J. E.
    van der Hoeven, Hans G.
    Schouten, Jeroen A.
    Frenzel, Tim
    Reijers, Monique H. E.
    Hoefsloot, Wouter
    Dofferhoff, Anton S. M.
    van Apeldoorn, Marjan J.
    Blaauw, Marc J. T.
    Veerman, Karin
    Maas, Coen
    Schoneveld, Arjan H.
    Hoefer, Imo E.
    Derde, Lennie P. G.
    van Deuren, Marcel
    van der Meer, Jos W. M.
    van Crevel, Reinout
    Giamarellos-Bourboulis, Evangelos J.
    Joosten, Leo A. B.
    van den Heuvel, Michel M.
    Hoogerwerf, Jacobien
    de Mast, Quirijn
    Pickkers, Peter
    Netea, Mihai G.
    van de Veerdonk, Frank L.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 223 (08): : 1322 - 1333
  • [24] Novel Coronavirus Disease (COVID-19) in Italian Patients: Gender Differences in Presentation and Severity
    Redaelli, Martina Baiardo
    Landoni, Giovanni
    Di Napoli, Davide
    Morselli, Federica
    Sartorelli, Marianna
    Sartini, Chiara
    Ruggeri, Annalisa
    Salonia, Andrea
    Dagna, Lorenzo
    Zangrillo, Alberto
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2021, 9 (01) : 59 - 62
  • [25] Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity
    Schwarz, Yair
    Percik, Ruth
    Oberman, Bernice
    Yaffe, Dana
    Zimlichman, Eyal
    Tirosh, Amir
    ENDOCRINE PRACTICE, 2021, 27 (02) : 101 - 109
  • [26] Severity of COVID-19 infection in prostate cancer patients and effect of ADT on disease presentation
    Garcia, Fuentes C.
    Jimenez, Alcaide E.
    Hernandez, V
    De La Pena, Zarzuelo E.
    Guijarro, Cascales A.
    Castro, Fajardo A.
    Perez-Fernandez, E.
    Llorente, C.
    EUROPEAN UROLOGY, 2021, 79 : S1186 - S1186
  • [27] Definition of the Immune Parameters Related to COVID-19 Severity
    Birindelli, Sarah
    Tarkowski, Maciej S.
    Gallucci, Marcello
    Schiuma, Marco
    Covizzi, Alice
    Lewkowicz, Przemyslaw
    Aloisio, Elena
    Falvella, Felicia Stefania
    Dolci, Alberto
    Riva, Agostino
    Galli, Massimo
    Panteghini, Mauro
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] Association of Immune Semaphorins with COVID-19 Severity and Outcomes
    Vargovic, Martina
    Papic, Neven
    Samadan, Lara
    Topic, Mirjana Balen
    Vince, Adriana
    BIOMEDICINES, 2023, 11 (10)
  • [29] COVID-19 disease and immune dysregulation
    Davitt, Ethan
    Davitt, Colin
    Mazer, Monty B.
    Areti, Sathya S.
    Hotchkiss, Richard S.
    Remy, Kenneth E.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2022, 35 (03)
  • [30] EFFECTS OF ATOPIC DISEASE ON DISEASE SEVERITY IN COVID-19
    Timberlake, D.
    Narayanan, D.
    Ogbogu, P.
    Raveendran, R.
    Prince, B.
    Scherzer, R.
    Porter, K.
    Grayson, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S43 - S43